These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12956932)

  • 1. Binding affinity to and dependence on some opioids in Sf9 insect cells expressing human mu-opioid receptor.
    Liu ZH; He Y; Jin WQ; Chen XJ; Zhang HP; Shen QX; Chi ZQ
    Acta Pharmacol Sin; 2003 Sep; 24(9):859-63. PubMed ID: 12956932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chronic treatment of ohmefentanyl stereoisomers on cyclic AMP formation in Sf9 insect cells expressing human mu-opioid receptors.
    Liu ZH; He Y; Jin WQ; Chen XJ; Shen QX; Chi ZQ
    Life Sci; 2004 Apr; 74(24):3001-8. PubMed ID: 15051423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical relationship between RAVE (relative activity versus endocytosis) values of several opioid receptor agonists and their liability to cause dependence.
    Wang YH; Sun JF; Tao YM; Xu XJ; Chi ZQ; Liu JG
    Acta Pharmacol Sin; 2010 Apr; 31(4):393-8. PubMed ID: 20228826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mu-opioid receptor overexpressed in baculovirus system and its pharmacological characterizations.
    Wei Q; Zhou DH; Shen QX; Wang CH; Chen J; Li CL; Pei G; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1998 May; 19(3):218-22. PubMed ID: 10375729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Internalization and recycling of human mu opioid receptors expressed in Sf9 insect cells.
    Chen LE; Gao C; Chen J; Xu XJ; Zhou DH; Chi ZQ
    Life Sci; 2003 May; 73(1):115-28. PubMed ID: 12726892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroetorphine is a mu-receptor-selective ligand.
    Wang DX; Lu XQ; Qin BY
    J Pharm Pharmacol; 1995 Aug; 47(8):669-73. PubMed ID: 8583370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence.
    Xu H; Partilla JS; Wang X; Rutherford JM; Tidgewell K; Prisinzano TE; Bohn LM; Rothman RB
    Synapse; 2007 Mar; 61(3):166-75. PubMed ID: 17152090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human mu-opioid receptor overexpressed in Sf9 insect cells functionally coupled to endogenous Gi/o proteins.
    Wei Q; Zhou DH; Shen QX; Chen J; Chen LW; Wang TL; Pei G; Chi ZQ
    Cell Res; 2000 Jun; 10(2):93-102. PubMed ID: 10896171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etorphines: mu-opioid receptor-selective antinociception and low physical dependence capacity.
    Aceto MD; Harris LS; Bowman ER
    Eur J Pharmacol; 1997 Nov; 338(3):215-23. PubMed ID: 9424015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid receptor regulation in mice.
    Yoburn BC; Billings B; Duttaroy A
    J Pharmacol Exp Ther; 1993 Apr; 265(1):314-20. PubMed ID: 8386239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TH-030418: a potent long-acting opioid analgesic with low dependence liability.
    Yu G; Yan LD; Li YL; Wen Q; Dong HJ; Gong ZH
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Aug; 384(2):125-31. PubMed ID: 21594658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of opioid receptor agonists on cAMP second messenger system.
    Liu JG; Gong ZH; Qin BY
    Zhongguo Yao Li Xue Bao; 1999 May; 20(5):452-6. PubMed ID: 10678096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice.
    Anand JP; Boyer BT; Mosberg HI; Jutkiewicz EM
    Psychopharmacology (Berl); 2016 Jul; 233(13):2479-87. PubMed ID: 27117141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
    Yoburn BC; Purohit V; Patel K; Zhang Q
    Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fentanyl and its analogs desensitize the cloned mu opioid receptor.
    Bot G; Blake AD; Li S; Reisine T
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1207-18. PubMed ID: 9618424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist and antagonist properties of dihydroetorphine for mu-opioid receptors in mice.
    Kamei J; Suzuki T; Nagase H
    Neurosci Lett; 1996 Sep; 215(2):87-90. PubMed ID: 8888002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor.
    Lu YF; Xu H; Liu-Chen LY; Chen C; Partilla JS; Brine GA; Carroll FI; Rice KC; Lai J; Porreca F; Sadee W; Rothman RB
    Synapse; 1998 Feb; 28(2):117-24. PubMed ID: 9450512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.